COMPARATIVE EVALUATION OF THE EFFECTIVENESS OF INNOVATIVE HIGH-TECH CARDIAC SURGERY IN PATIENTS WHO HAVE SUFFERED AN ACUTE MYOCARDIAL INFARCTION

The proposed scientific article discusses the results of evaluating the medical and social effectiveness of innovative high-tech cardiac surgery for patients who have suffered an acute myocardial infarction. It was established that the inpatient mortality rate of patients who did not receive innovative high-tech cardiac surgery is significantly higher than in those patients who received it. These differences are particularly noticeable when comparing data among the elderly. A comprehensive assessment of the effectiveness of implementing high-tech medical services in the field of cardiovascular system includes an analysis of medical and statistical, sociological methods, financial and economic, organizational and managerial methods, as well as an assessment of the level of application of relevant regulations. The results of a study using a logarithmic test showed that stenting of coronary vessels and aorta-coronary bypass surgery significantly reduce hospital mortality in patients with myocardial infarction in all age groups. The hospital mortality rate among patients of the main (who have received HTMC) age group was 0.96%, and among patients of the control (who haven't received HTMC) group - 11.84% (p=0.002). There was no significant reduction in mortality among the group of old patients (p=0.779). Thus, the largest difference in hospital mortality between the main and control groups was found only in elderly patients, p=0.002. the effectiveness of the achieved success depends not only on the introduction of innovative technology, but also on the availability of highly qualified cardiac surgeons and basic medical material and technical resources.